Anew Labs raised $290 million at a $1.5 billion valuation. Explore ByteDance’s stake and the gap between AI research and approved medicines.
Explore reported AI misuse in biological research and the debate over evaluations, verification, oversight, and responsible access.
AI toilet devices promise health insights. Explore the evidence limits, intimate data collection, subscription costs, and risks of false alerts.
A debate over autonomous medical AI raises questions about real-world evidence, physician oversight, training, communication, and patient safety.
Bill Gates urges US–China coordination on AI biosecurity safeguards while preserving beneficial healthcare research.
